Background Hypoglycemia is the most common metabolic issue in newborns and should be treated as soon as possible to prevent complications of neurologic impairment, mental retardation, developmental delay, and cardiovascular disorders. Objective To assess maternal, fetal, and neonatal factors for identifying infants at risk of developing neonatal hypoglycemia. Methods This case-control study was conducted in the Perinatal Unit of Dr. Kariadi Hospital, Semarang, Central Java. A total of 123 newborns with blood glucose <47 mg/ dL comprised the case group and 123 newborns without hypoglycemia comprised the control group. Characteristics of infants, maternal age, maternal pregnancy-related conditions, as well as fetal and neonatal factors were recorded and analyzed for possible relationships with hypoglycemia. Results Out of 677 newborns, hypoglycemia was found in 123 (18.2%) infants (59 male, 64 female). In hypoglycemic group, 47.1% were preterm, 30.9% very preterm, and 6.5% extremely preterm infants. Factors associated with neonatal hypoglycemia were prematurity (OR 6.537; 95%CI 3.543 to 12.063; P <0.001), low birth weight (OR 2.979; 95% CI 1.532 to 5.795; P<0.001), small for gestational age (OR 1.805; 95% CI 1.054 to 3.095; P=0.031), and birth asphyxia (OR 3.386; 95% CI 1.945 to 5.895; P<0.001). In multivariate regression analysis, prematurity and low birth weight remained the significant factors associated with neonatal hypoglycemia. Conclusion Prematurity and, low birth weight are significant risk factors associated with neonatal hypoglycemia. Routine screening and monitoring of blood glucose is recommended for preterm newborns and infants with low birth weight. [Paediatr Indones. 2019;59:252-6; doi: http:// dx.
H ypoglycemia is the most common metabolic issue in newborns and should be treated as soon as possible to prevent complications of neurological impairment, mental retardation, developmental delay, and debilitating cardiovascular function. 1 It is important to recognize hypoglycemia in order to initiate prompt treatment and prevent long-term neurologic damage. Hypoglycemia is mostly asymptomatic, but timely and accurate recognition is important to achieve optimal neonatal outcomes. 2 We aimed to assess maternal, fetal, and neonatal factors for identifying infants at risk of developing neonatal hypoglycemia.
Methods
This case-control study was conducted in the Perinatal Unit of Dr. Kariadi Hospital, Semarang, Central Java, Indonesia. Data were obtained from medical records of infants born in 2017. Fullterm was defined as baby born after 37 weeks of pregnancy; meanwhile, preterm was defined as baby born before 37 weeks of pregnancy and divided into very preterm (28-32 weeks) and extremely preterm (less than 28 weeks). Babies born with birthweight between 2500 -3999 g were considered as normal birthweight; low birth weight (LBW) was defined as a birth weight of less than 2500 g which further categorized into very low birth weight (<1500 g) and extremely low birth weight (<1000 g). Birth asphyxia was defined as the failure to establish breathing at birth defined based on the 5th min Apgar score of <7. Blood glucose levels documented in medical records were measured from a heel puncture blood sample.
Patients born to diabetic mothers or with multiple congenital anomalies were excluded. A total of 123 newborns with blood glucose <47 mg/dL comprised the case group. 
Results
Characteristics of subjects are shown in Table 1 . Of 677 newborns hospitalized in year 2017, hypoglycemia was found in 123 (18.2%) infants (59 male, 64 female). Of the case group, a total of 65 (52.8%) were born via caesarean delivery, maternal age were mostly <35 years (79.7%), and multiparous (65%). Table 2 shows that in the case group, hypoglycemia was found mostly in infants born less than 37 weeks consisted of 58 (47.1%) preterm, 38 (30.9%) very preterm, and 8 (6.5%) extremely preterm infants. A total of 89 (72.3%) were born with low birth weight, 25 (20.3%) were born very low birth weight, and 5 (4%) infants were born with extremely low birth weight. In addition, 49 (39.9%) infants were born small for gestational age (SGA). Factors associated with neonatal hypoglycemia were prematurity (OR 6.537; 95% CI 3.543 to 12.063; P<0.001), birth weight less than 2,500 g (OR 2.979; 95%CI 1.532 to 5.795; P<0.001), SGA (OR 1.805; 95%CI 1.054 to 3.095; P=0.031), and birth asphyxia (OR 3.386; 95%CI 1.945 to 5.895; P<0.001).
Multivariate regression analysis as shown in Table 3 revealed that prematurity and low birth weight were the significant factors associated with neonatal hypoglycemia. None of the other maternal or fetal conditions were associated with the occurrence of neonatal hypoglycemia in our study. 
Discussion
Among infants born at <37 weeks, we observed an increased risk of neonatal hypoglycemia. The incidences of hypoglycemia among preterm, very preterm, and extremely preterm newborns in our study were 47.1%, 30.9%, and 6.5%, respectively. The prevalence of hypoglycemia in our study was higher than that of Bromiker et al., 2 however, they found that prematurity as the strongest risk factor for neonatal hypoglycemia. Preterm neonates are at risk of developing hypoglycemia and its associated complications due to their low reserve of glycogen and fat stores, inefficient production of glucose using gluconeogenesis pathways, higher metabolic requirement due to a relatively larger brain size, and inadequate ability to escalate a counter-regulatory response to hypoglycemia. 3 Birth weight was found to be one of the significant risk factors associated with hypoglycemia in our study. In hypoglycemic infants, 72.3%, 20.3%, and 4% were LBW, VLBW, and ELBW infants, respectively. Similarly, Kumar et al. 4 reported a higher percentage LBW babies in their hypoglycemic group (64% LBW vs. 14% NBW). They found that LBW infants were susceptible to developing hypoglycemia mainly in first 24 hours of life, with late introduction of breastfeeding being an additional risk. Low birth weight neonates are born with low stores of glycogen and adipose tissues as well as inadequate capacity to produce glucose through the gluconeogenesis pathway or disproportionate peripheral tissue utilization of glucose. Hence, such infants are prone to hypoglycemia. 3 Hypoglycemia was present in 59.8% of the SGA infants. These findings were consistent with those of Ho et al. 5 who reported an incidence of 34.2% in SGA infants. The neonatal brain and vital organs need a steady supply of glucose to meet nutritional demands. In full term and healthy neonates, this is accomplished by hormonal and metabolic adaptive changes. Preterm and SGA neonates are prone to hypoglycemia due to their limited glucose storage, insufficient adaptive changes, and underdeveloped metabolic pathways. 6 A previous study reported lower cord blood glucose levels in Caesarean-delivered newborns. 7 However, we found no significant difference in Caesarean-delivered vs. vaginally-delivered newborns for the two groups. This finding might have been due to the limited sample size of our study and the different method of measuring the blood glucose level as we took the samples from peripheral blood specimen.
Of hypoglycemic infants, 48.8% had birth asphyxia. The risk of developing hypoglycemia increased three-fold compared to vigorous-born infants. A previous study reported an incidence of 26.86% hypoglycemia among infants born with birth asphyxia. 8 During asphyxia, an increased anaerobic glycolysis rate along with glycogenolysis predisposes neonates to hypoglycemia. 9 The main limitation of this study was its susceptibility to information bias, as data collected reflected what was recorded in the medical charts. Many factors may affect the prevalence of neonatal hypoglycemia in different medical centers. Thus, performing a hospital-based study in this regard is important to establish comprehensive neonatal care guidelines to reduce neonatal mortality and morbidity caused by hypoglycemia among newborns at risk.
In conclusion, prematurity and low birth weight are significant risk factors associated with neonatal hypoglycemia. Routine screening and monitoring of blood glucose is recommended for preterm newborns and infants with low birth weight.
